placeholder image
B. J. Lewin All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the Vaccine Safety Datalink, 2022-2023. 
    Human Vaccines & Immunotherapeutics. 2025
  • COVID-19 and completion of select routine childhood vaccinations. 
    Pediatrics. 2025
  • Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis. 
    Lancet Reg Health Am. 2025
  • Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States. 
    Clinical Infectious Diseases. 2025
  • JYNNEOS vaccine safety surveillance in the vaccine safety datalink during the 2022 mpox outbreak in the United States. 
    Infection. 2025
  • Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024. 
    Clinical Infectious Diseases. 2025
  • Religious service attendance, COVID-19 vaccine attitudes, and COVID-19 vaccination status: a Vaccine Safety Datalink member survey, 2022-2023. 
    AJPM Focus. 2025
  • Risk of immune thrombocytopenic purpura recurrence following second measles-containing vaccine dose. 
    Pediatrics. 2025
  • Influenza vaccination accuracy among adults: self-report compared with electronic health record data. 
    Vaccine. 2024
  • Lack of evidence for vaccine-associated enhanced disease from COVID-19 vaccines among adults in the Vaccine Safety Datalink. 
    Pharmacoepidemiology and Drug Safety. 2024
  • Mortality risk after COVID-19 vaccination: a self-controlled case series study. 
    Vaccine. 2024
  • Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. 
    Nature communications. 2024
  • Influenza vaccination among pregnant women: self-report compared with vaccination data from electronic health records, 2018-2020 influenza seasons. 
    Public Health Reports. 2023
  • Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: the contribution of vaccine-related attitudes. 
    Preventive Medicine. 2023
  • Health care utilization in the 6 months following SARS-CoV-2 infection. 
    JAMA network open. 2022
  • Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. 
    Vaccine. 2022
  • Safety of COVID-19 vaccination in United States children ages 5 to 11 years. 
    Pediatrics. 2022
  • Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink. 
    Vaccine. 2022
  • 16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021. 
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Surveillance for adverse events after COVID-19 mRNA vaccination. 
    JAMA. 2021
  • The childhood vaccination schedule and the lack of association with type 1 diabetes. 
    Pediatrics. 2021
  • Association between rotavirus vaccination and type 1 diabetes in children. 
    JAMA pediatrics. 2020
  • Order of live and inactivated vaccines and risk of non-vaccine-targeted infections in US children 11-23 months of age. 
    Pediatric Infectious Disease Journal. 2020
  • Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age. 
    JAMA. 2018
    • Contact
    full name
  • B. J. Lewin
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration